Medical Workspace
| Treating | Evaluating | ||
|---|---|---|---|
|
Dr. Angela Martinez
PTP · Orthopedics
|
Dr. James Wu
QME · Orthopedics
|
Dr. Patricia Singh
AME · Pain Management
|
|
| Report Date | Nov 14, 2023 | Mar 8, 2024 | Apr 2, 2024 |
| MMI Date | Jan 15, 2024 | Mar 8, 2024 | Apr 2, 2024 |
| WPI Rating | 22% | 45% | 35% |
| DRE Category | Lumbar Category II | Lumbar Category IV | Lumbar Category III |
| Disability Status | TD — Temporary | P&S — Permanent 45% | P&S — Permanent 35% |
| Future Medical | Ongoing conservative care | Yes — surgery + pain mgmt | Yes — conservative, surgical if fails |
| Causation | 100% industrial | 100% industrial | 85% industrial |
| Apportionment | None | None | 15% pre-existing |
| Work Status | Sedentary only | Sedentary only | Modified duty |
| Surgery Rec. | Not recommended | L4–L5 ACDF | Conservative care first |
Under CA Labor Code §4628(b), the AME's opinion (Dr. Singh, 35% WPI) is generally controlling where parties agreed to an AME panel. The 23-point spread between PTP (22%) and QME (45%) opinions elevates dispute risk significantly. Dr. Singh's 15% apportionment to pre-existing condition will reduce the final PD award. Confirm AME agreement status before proceeding to MSC.
The L4–L5 disc herniation (M51.16) is the primary compensable injury and the basis for the permanent disability dispute. The right knee contusion resolved without permanent impairment. No additional diagnoses were raised by any provider. The QME's DRE Lumbar Category IV classification (vs. PTP's Category II) is the root cause of the WPI conflict.
Aug 14, 2023
| Requested | Treatment | Requested By | UR Decision | Decision Date | Status |
|---|---|---|---|---|---|
| Oct 3, 2023 |
MRI Lumbar Spine w/ Contrast
L4–L5 · Pacific Imaging Group
|
Dr. A. Martinez (PTP) | Approved | Oct 12, 2023 | Complete |
| Dec 1, 2023 |
Pain Management Consultation
Initial eval · Pacific Interventional Pain
|
Dr. A. Martinez (PTP) | Approved | Dec 8, 2023 | Complete |
| Jan 15, 2024 |
Repeat MRI Lumbar Spine
Follow-up post-injection · Pacific Imaging Group
|
Dr. P. Singh (AME) | Approved | Jan 22, 2024 | Complete |
| Apr 10, 2024 |
L4–L5 Lumbar Fusion Surgery (ACDF)
Per QME rec. · Pacific Spine Surgery Center
|
Dr. J. Wu (QME) | Denied | Apr 22, 2024 | IMR Filed |
| Jun 5, 2024 |
Spinal Cord Stimulator Trial
6-week trial · Pacific Interventional Pain
|
Dr. P. Singh (AME) | Denied | Jun 14, 2024 | IMR Filed |
| Jun 20, 2024 |
Physical Therapy — Continuation
12 additional sessions · Pacific Coast PT
|
Dr. A. Martinez (PTP) | Approved | Jun 26, 2024 | In Progress |
The IMR denial of L4–L5 fusion (IMR #1, Jun 18) is grounded in MTUS §9792.20 — conservative care exhaustion is the threshold and the record shows only two ESIs and 47 PT sessions. The most defensible path to surgical approval is documented failure of a third ESI plus extended PT with objective functional measures. For IMR #2 (SCS trial), AME Dr. Singh's support is favorable but SCS carries a high evidentiary bar under current MTUS; outcome is uncertain. Action required: WCAB appeal deadline for IMR #1 is Jul 18, 2024 — confirm with supervising attorney whether to appeal or continue conservative care pathway.